Skip to content

Incidence of Glaucoma-related Adverse Events in Pediatric Secondary Intraocular Lens Implantation

Incidence of Glaucoma-related Adverse Events in Pediatric Secondary Intraocular Lens Implantation, In-the-bag Versus Sulcus Fixation : a Randomized Controlled Trial

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05136950
Enrollment
228
Registered
2021-11-30
Start date
2021-12-14
Completion date
2033-07-30
Last updated
2022-01-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lens Implantation, Intraocular

Keywords

Pediatric aphakia, Secondary Intraocular Lens Implantation, Glaucoma-related Adverse Events, In-the-bag IOL implantation, Sulcus IOL fixation

Brief summary

To compare the incidence of glaucoma-related adverse events of in-the-bag versus ciliary-sulcus-fixed secondary intraocular lens (IOL) implantation in pediatric aphakia

Detailed description

Treatment of pediatric cataract, one of the leading causes of childhood blindness globally, remains challenging because of extremely high incidence of glaucoma-related adverse events (AEs) after IOL implantation. The investigators aim to compare the incidence of glaucoma-related AEs of in-the-bag versus ciliary-sulcus-fixed secondary intraocular lens (IOL) implantation in pediatric aphakia.

Interventions

PROCEDURESecondary in-the-bag IOL fixation

The experimental group with secondary IOL fixated in the capsular bag

PROCEDURESecondary ciliary sulcus IOL fixation

The control group with secondary IOL fixated in the ciliary sulcus

Sponsors

Zhongshan Ophthalmic Center, Sun Yat-sen University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Months to 14 Years
Healthy volunteers
No

Inclusion criteria

* Aged between 18 months and 14 years * Had a primary diagnosis of congenital cataract. * Underwent cataract extraction between the ages of 2 and 24 months

Exclusion criteria

* Primary IOL implantation * Pre-existing ocular disease which might affect the location and outcome of secondary IOL implantation (including and not restricted to microphthalmia, microcornea, microcornea, corneal opacity, pseudopterygium, iris anomaly, glaucoma diagnosed before cataract extraction, uveitis, persistent fetal vasculature or trauma) * Suture fixation for secondary IOL implantation

Design outcomes

Primary

MeasureTime frameDescription
Incidence of glaucoma-related adverse eventsOne year after surgeryThe assessment of glaucoma-related adverse events is performed at one year after surgery

Secondary

MeasureTime frameDescription
Visual acuitySix months,one year, three years, five years, ten years after surgeryEvaluated with an ETDRS chart. For those who are unable to use ETDRS chart, visual acuity will be evaluated with Lea Symbol Chart or Teller Acuity Cards
Ocular refractive powerSix months,one year,three years, five years, ten years after surgeryMeasured by the Auto Refractometer
Incidence of glaucoma-related adverse eventsSix months,three years, five years, ten years after surgeryThe assessment of glaucoma-related AEs is performed at six months, three years, five years, ten years after surgery
Intraocular lens tiltSix months,one year, three years, five years, ten years after surgeryMeasured by anterior segment scanning
Incidence of other adverse eventsSix months,one year, three years, five years, ten years after surgeryThe assessment of other adverse events will be performed at six months,one year,three years, five years, ten years after surgery
Intraocular lens decentrationSix months,one year, three years, five years, ten years after surgeryMeasured by anterior segment scanning

Countries

China

Contacts

Primary ContactZhenzhen Liu, PhD
liu_zhenzhen@qq.com+86 13570382241

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 9, 2026